JP2010284165A5 - - Google Patents

Download PDF

Info

Publication number
JP2010284165A5
JP2010284165A5 JP2010159956A JP2010159956A JP2010284165A5 JP 2010284165 A5 JP2010284165 A5 JP 2010284165A5 JP 2010159956 A JP2010159956 A JP 2010159956A JP 2010159956 A JP2010159956 A JP 2010159956A JP 2010284165 A5 JP2010284165 A5 JP 2010284165A5
Authority
JP
Japan
Prior art keywords
gram
negative bacterium
mutation
gene
pasteurellaceae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010159956A
Other languages
English (en)
Japanese (ja)
Other versions
JP5377433B2 (ja
JP2010284165A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2010284165A publication Critical patent/JP2010284165A/ja
Publication of JP2010284165A5 publication Critical patent/JP2010284165A5/ja
Application granted granted Critical
Publication of JP5377433B2 publication Critical patent/JP5377433B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2010159956A 1999-04-09 2010-07-14 抗菌ワクチン組成物 Expired - Fee Related JP5377433B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US12868999P 1999-04-09 1999-04-09
US60/128,689 1999-04-09
US15345399P 1999-09-10 1999-09-10
US60/153,453 1999-09-10

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2000611649A Division JP4892134B2 (ja) 1999-04-09 2000-04-06 抗菌ワクチン組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012281231A Division JP2013121347A (ja) 1999-04-09 2012-12-25 抗菌ワクチン組成物

Publications (3)

Publication Number Publication Date
JP2010284165A JP2010284165A (ja) 2010-12-24
JP2010284165A5 true JP2010284165A5 (OSRAM) 2011-12-22
JP5377433B2 JP5377433B2 (ja) 2013-12-25

Family

ID=26826843

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2000611649A Expired - Lifetime JP4892134B2 (ja) 1999-04-09 2000-04-06 抗菌ワクチン組成物
JP2010159956A Expired - Fee Related JP5377433B2 (ja) 1999-04-09 2010-07-14 抗菌ワクチン組成物
JP2012281231A Pending JP2013121347A (ja) 1999-04-09 2012-12-25 抗菌ワクチン組成物
JP2015153261A Expired - Fee Related JP5973634B2 (ja) 1999-04-09 2015-08-03 抗菌ワクチン組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2000611649A Expired - Lifetime JP4892134B2 (ja) 1999-04-09 2000-04-06 抗菌ワクチン組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2012281231A Pending JP2013121347A (ja) 1999-04-09 2012-12-25 抗菌ワクチン組成物
JP2015153261A Expired - Fee Related JP5973634B2 (ja) 1999-04-09 2015-08-03 抗菌ワクチン組成物

Country Status (14)

Country Link
US (5) US20070237793A1 (OSRAM)
EP (5) EP2281833B1 (OSRAM)
JP (4) JP4892134B2 (OSRAM)
KR (4) KR20060116041A (OSRAM)
CN (1) CN1351653A (OSRAM)
AR (1) AR029622A1 (OSRAM)
AU (2) AU780887B2 (OSRAM)
BR (1) BR0009663A (OSRAM)
CA (1) CA2366520C (OSRAM)
ES (2) ES2439645T3 (OSRAM)
HK (1) HK1045856A1 (OSRAM)
MX (1) MXPA01010207A (OSRAM)
NZ (2) NZ530012A (OSRAM)
WO (1) WO2000061724A2 (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4892134B2 (ja) * 1999-04-09 2012-03-07 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗菌ワクチン組成物
US6790950B2 (en) 1999-04-09 2004-09-14 Pharmacia & Upjohn Company Anti-bacterial vaccine compositions
JP4124732B2 (ja) 2001-09-26 2008-07-23 協和醗酵工業株式会社 α１，４−ガラクトース転移酵素およびガラクトース含有複合糖質の製造法
DE60230717D1 (de) * 2002-04-05 2009-02-26 Merial Sas Attenuirte Gram-negative Bakterien
US7449178B2 (en) 2002-04-05 2008-11-11 Merial Limited Attenuated gram negative bacteria
GB0228691D0 (en) * 2002-12-09 2003-01-15 Imp College Innovations Ltd Bacterial virulence genes
ATE486936T1 (de) * 2003-03-05 2010-11-15 Chemo Sero Therapeut Res Inst Verfahren zur herstellung eines heterologen proteins in e. coli
US8937154B2 (en) 2006-10-05 2015-01-20 New York Blood Center, Inc. Stabilized therapeutic small helical antiviral peptides
EP2073829B1 (en) * 2006-10-05 2012-06-20 New York Blood Center, Inc. Stabilized therapeutic small helical antiviral peptides
JP2011522796A (ja) 2008-05-06 2011-08-04 ニューヨーク ブラッド センター， インコーポレイテッド 抗ウイルス細胞透過性ペプチド
DE102011016772B8 (de) * 2011-04-12 2024-08-14 Mercedes-Benz Group AG Verfahren und Vorrichtung zur Überwachung zumindest eines Fahrzeuginsassen und Verfahren zum Betrieb zumindest einer Assistenzvorrichtung
US9757445B2 (en) 2013-11-01 2017-09-12 Merial Inc. Attenuated Pasteurella multocida vaccines and methods of making and use thereof
ES2945137T3 (es) 2017-02-10 2023-06-28 Epitopix Llc Proteínas y composiciones inmunitarias que contienen proteínas de Pasteurella y métodos de uso
TW202219269A (zh) 2020-09-30 2022-05-16 美國農業部 新型多殺性巴斯德氏菌株及具有ｈｙａＣ與ｎａｎＰ缺失之疫苗
TW202214294A (zh) 2020-09-30 2022-04-16 美商碩騰服務公司 具有ｈｙａＣ及ｎａｎＰ缺失之新穎多殺性巴斯德氏菌株及疫苗
CN113567415A (zh) * 2021-07-05 2021-10-29 广西大学 表面增强拉曼散射结合免疫层析技术检测布鲁氏杆菌方法
CN115925536B (zh) * 2022-08-01 2025-02-28 北京农学院 靶向抑制DksA的小分子抑制剂和应用
CN116593695B (zh) * 2022-12-29 2025-08-05 重庆澳龙生物制品有限公司 一种牛多杀性巴氏杆菌荚膜a型elisa抗体检测试剂盒及其制备方法和应用

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL52815A (en) * 1977-08-24 1983-03-31 Israel State Fowl cholera vaccine and process for producing an attenuated non-virulent strain of pasteurella multocida
US4735801A (en) * 1982-09-07 1988-04-05 Board Of Trustees Of Leland Stanford Jr. University Novel non-reverting salmonella live vaccines
US5077044A (en) * 1980-05-19 1991-12-31 The Board Of Trustees Of The Leland Stanford Jr. University Novel non-reverting shigella live vaccines
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
DE3426532A1 (de) 1984-07-18 1986-01-30 Gesellschaft für Biotechnologische Forschung mbH (GBF), 3300 Braunschweig Verwendung einer dna-sequenz zur expression sowie dna-struktur und expressionsvektor mit der dna-sequenz
SE8405493D0 (sv) 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US4877612A (en) 1985-05-20 1989-10-31 Frank M. Berger Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process
DK166762B1 (da) 1986-01-14 1993-07-12 Nederlanden Staat Fremgangsmaade til fremstilling af immunogenkomplekser og farmaceutisk sammensaetning indeholdende saadanne komplekser
US4806352A (en) 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
CA1340522C (en) 1987-03-10 1999-05-04 Heinz Dobeli Fusion proteins containing neighbouring histidines for improved purification
IL86583A0 (en) * 1987-06-04 1988-11-15 Molecular Eng Ass Vaccine containing a derivative of a microbe and method for the production thereof
US5376369A (en) * 1987-11-03 1994-12-27 Syntex (U.S.A.) Inc. Vaccine adjuvant
DK46693D0 (OSRAM) * 1993-04-23 1993-04-23 Novo Nordisk As
PL170938B1 (pl) * 1991-03-05 1997-02-28 Wellcome Found Sposób wytwarzania szczepionki przeciwko infekcjom Salmonella PL PL
US5840312A (en) * 1991-05-02 1998-11-24 Institut Pasteur Recombinant Bacillus anthracis strains unable to produce the lethal factor protein or edema factor protein
WO1994011024A1 (en) * 1992-11-06 1994-05-26 Regents Of The University Of Minnesota Composition protective against p. multocida pasteurellosis infection
US5585277A (en) 1993-06-21 1996-12-17 Scriptgen Pharmaceuticals, Inc. Screening method for identifying ligands for target proteins
US5587305A (en) 1993-12-06 1996-12-24 The United States Of America As Represented By The Department Of Agriculture Pasteurella haemolytica transformants
WO1995020652A1 (de) 1994-01-28 1995-08-03 Medigene Gmbh Verfahren zur bestimmung der aktivität eines regulatorischen faktors sowie verwendung dieses verfahrens
DE69535674T2 (de) 1994-08-30 2009-01-02 Ajinomoto Co., Inc. Verfahren zur herstellung von l-valin und l-leucin
KR100445103B1 (ko) * 1994-12-09 2004-12-04 임페리얼 컬리지 이노베이션스 리미티드 유전자의동정
CA2170839A1 (en) * 1995-03-01 1996-09-02 Janet Macinnes Bacterial preparations, method for producing same, and their use as vaccines
US6355450B1 (en) 1995-04-21 2002-03-12 Human Genome Sciences, Inc. Computer readable genomic sequence of Haemophilus influenzae Rd, fragments thereof, and uses thereof
GB9518220D0 (en) 1995-09-06 1995-11-08 Medical Res Council Checkpoint gene
US5994066A (en) 1995-09-11 1999-11-30 Infectio Diagnostic, Inc. Species-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
US5925354A (en) * 1995-11-30 1999-07-20 Michigan State University Riboflavin mutants as vaccines against Actinobacillus pleuropneumoniae
US5840556A (en) * 1996-05-08 1998-11-24 The United States Of America As Represented By The Department Of Agriculture Molecular genetic construction of vaccine strains of pasteurellaceae
JPH1075774A (ja) * 1996-05-31 1998-03-24 Akzo Nobel Nv パスツレラ科の弱毒化ｒｔｘ産生細菌
US6020474A (en) 1997-01-15 2000-02-01 Incyte Pharmaceuticals, Inc. ATP synthase subunits
US6673538B1 (en) 1997-07-25 2004-01-06 The Trustees Of Boston University Methods and compositions for designing vaccines
US6790950B2 (en) 1999-04-09 2004-09-14 Pharmacia & Upjohn Company Anti-bacterial vaccine compositions
JP4892134B2 (ja) * 1999-04-09 2012-03-07 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗菌ワクチン組成物
AU7131600A (en) 1999-06-21 2001-01-09 North Carolina State University Acid-inducible promoters for gene expression
US6376211B1 (en) 1999-07-12 2002-04-23 Xoma Technology Ltd. Agents and methods for inhibiting F1/F0 ATPase

Similar Documents

Publication Publication Date Title
JP2010284165A5 (OSRAM)
Kuo et al. Functional characterization of Acinetobacter baumannii lacking the RNA chaperone Hfq
CN1671845A (zh) 免疫原序列
JP2008538183A5 (OSRAM)
US8734814B2 (en) Recombinant microorganisms and uses thereof
JP2011004753A5 (OSRAM)
JP2011507500A5 (OSRAM)
RU2010130338A (ru) Мутантные формы стрептолизина о
JP2013538554A5 (OSRAM)
JP2015533791A5 (OSRAM)
NZ593893A (en) Gene encoding human glucokinase mutant, enzyme encoded by the same, recombinant vectors and hosts, pharmaceutical compositions and uses thereof, methods for treating and preventing diseases
JP2013531491A5 (OSRAM)
JP2005502315A5 (OSRAM)
Kim et al. Recent trends of antigenic variation in Bordetella pertussis isolates in Korea
JP2017536124A5 (OSRAM)
JP2020502075A5 (OSRAM)
NZ614557A (en) Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
CN101780273A (zh) 一种哈氏弧菌分泌型疫苗及其构建和应用
CN103394098B (zh) 一种大菱鲆自然杀伤细胞增强因子表达载体的应用
MX2023001219A (es) Constructos de vacuna y sus usos contra infecciones causadas por staphylococcus.
CN101294144A (zh) 2型猪链球菌sa1KR基因敲除突变株及其制备方法和应用
Zhang et al. Identification and analysis of three virulence-associated TonB-dependent outer membrane receptors of Pseudomonas fluorescens
JP2016086711A5 (OSRAM)
CN103555645B (zh) 一种不含抗性标记的猪传染性胸膜肺炎弱毒活疫苗及其用途
JP2009507474A5 (OSRAM)